OverviewChartNewsTraderScreen

Soc. Generale Knock-Out PGR/  DE000SY2D589  /

Frankfurt Zert./SG
8/15/2024  10:01:47 AM Chg.+1.000 Bid9:29:51 AM Ask9:29:51 AM Underlying Strike price Expiration date Option type
3.700EUR +37.04% 3.860
Bid Size: 6,000		 4.250
Ask Size: 6,000		 Progressive Corporat... 192.4338 USD 12/31/2078 Call
Newsfile Corp 8/12 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
TeleTrader 8/11 Bank of Russia says rates could reach 20%
TeleTrader 8/7 Cori Bush loses Missouri Democratic primary
TeleTrader 8/6 Aramco's Q2 net income down 3.2% to $29.1 billion
TeleTrader 7/29 Putin congratulates Maduro on election victory
TeleTrader 7/27 G20 agrees to work together to tax billionaires
TeleTrader 7/25 Nikki Haley not surprised by Biden's presidential race exit
TeleTrader 7/15 Syrians head to polls for parliamentary elections
TeleTrader 7/13 Progressive Caucus meets with Biden
TeleTrader 7/11 Peskov: NATO nears Russia's borders, could provoke response
TeleTrader 7/8 Lula proud of France's fight against 'extremism'
TeleTrader 7/5 Trudeau, Albanese welcome Labour Party's landslide victory
GlobeNewswire 6/25 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire 6/25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 6/24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire 6/24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 6/24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire 6/19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 6/18 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 6/14 Progressive Reports May 2024 Results
GlobeNewswire 6/13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 6/12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 6/12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 6/11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 6/11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...